Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xenex is a private healthcare technology and medical device company that develops ultraviolet disinfection systems used primarily by hospitals and other healthcare facilities to reduce environmental pathogen transmission. Its core products are LightStrike UV robots that use patented pulsed xenon, broad-spectrum UV light for whole-room microbial reduction and surface decontamination as an adjunct to manual cleaning. The company positions its offerings around infection prevention, hospital throughput, implementation support, and evidence-based environmental hygiene programs rather than drug development. Xenex has expanded product commercialization across healthcare and selected adjacent settings, and has highlighted FDA authorization for LightStrike+ and Health Canada registration for LightStrike6. For a biotech or healthcare analyst, Xenex is best understood as a commercial-stage infection prevention device company focused on disinfection workflow, pathogen reduction, and healthcare facility safety.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xenex.